13F HOLDINGS REPORT
Novo Holdings A/S
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0000950123-23-007714
Total Value
$1.29B
Positions
41
Other Managers
0
Confidential Omitted
No
Holdings (41)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ASML HOLDING N V | ASMLF | 197,760 | $143.3M | 11.07% |
| 2 | SALESFORCE.COM, INC. | CRM | 530,500 | $112.1M | 8.66% |
| 3 | LANZATECH GLOBAL INC | LNZAW | 15,814,845 | $108.0M | 8.35% |
| 4 | CORCEPT THERAPEUTICS INC | CORT | 3,377,768 | $75.2M | 5.81% |
| 5 | TAIWAN SEMICONDUCTOR MFG LTD | 874039100 | 710,780 | $71.7M | 5.54% |
| 6 | CABLE ONE INC | CABO | 94,103 | $61.8M | 4.78% |
| 7 | DISC MEDICINE, INC. | IRON | 1,090,772 | $48.4M | 3.74% |
| 8 | EDGEWISE THERAPEUTICS INC | EWTX | 6,071,703 | $47.1M | 3.64% |
| 9 | MIRUM PHARMACEUTICALS INC | MIRM | 1,684,193 | $43.6M | 3.37% |
| 10 | APPLE INC | AAPL | 221,460 | $43.0M | 3.32% |
| 11 | VAXCYTE INC | PCVX | 845,000 | $42.2M | 3.26% |
| 12 | ALIBABA GROUP HLDG LTD | BBAAY | 500,827 | $41.7M | 3.23% |
| 13 | BIOMARIN PHARMACEUTICAL INC | BMRN | 400,000 | $34.7M | 2.68% |
| 14 | ARCELLX, INC. | ACLX | 1,000,000 | $31.6M | 2.44% |
| 15 | SEAGEN INC. | SE | 159,986 | $30.8M | 2.38% |
| 16 | BLUEPRINT MEDICINES CORP | 09627Y109 | 448,804 | $28.4M | 2.19% |
| 17 | INSMED INC | INSM | 1,339,304 | $28.3M | 2.18% |
| 18 | AMICUS THERAPEUTICS INC | FOLD | 2,095,900 | $26.3M | 2.03% |
| 19 | ALNYLAM PHARMACEUTICALS INC | ALNY | 118,383 | $22.5M | 1.74% |
| 20 | CYMABAY THERAPEUTICS INC | 23257D103 | 2,000,000 | $21.9M | 1.69% |
| 21 | RENEO PHARMACEUTICALS INC | 75974E103 | 3,330,377 | $21.8M | 1.69% |
| 22 | BROOKFIELD ASSET MGMT INC | 112585104 | 627,207 | $20.5M | 1.58% |
| 23 | PHARVARIS N V | PHVS | 1,329,325 | $20.1M | 1.56% |
| 24 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,100,000 | $19.8M | 1.53% |
| 25 | ROCKET PHARMACEUTICALS INC | RCKTW | 920,000 | $18.3M | 1.41% |
| 26 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 1,000,000 | $18.1M | 1.40% |
| 27 | SPRUCE BIOSCIENCES INC | SPRB | 6,722,336 | $14.5M | 1.12% |
| 28 | RALLYBIO CORP | RLYB | 2,187,999 | $12.4M | 0.96% |
| 29 | SILK RD MED INC | 82710M100 | 333,884 | $10.8M | 0.84% |
| 30 | INSPIRE MED SYS INC | 457730109 | 32,500 | $10.6M | 0.82% |
| 31 | CYTEIR THERAPEUTICS INC | 23284P103 | 3,662,636 | $9.5M | 0.74% |
| 32 | VERVE THERAPEUTICS INC | 92539P101 | 500,000 | $9.4M | 0.72% |
| 33 | TREACE MED CONCEPTS INC | 89455T109 | 360,000 | $9.2M | 0.71% |
| 34 | ABCELLERA BIOLOGICS INC | ABCL | 1,126,915 | $7.3M | 0.56% |
| 35 | GALERA THERAPEUTICS INC | GRTX | 2,100,000 | $6.6M | 0.51% |
| 36 | IO BIOTECH INC | IOBT | 3,277,932 | $6.4M | 0.50% |
| 37 | GALECTO INC | 36322Q107 | 2,497,791 | $6.3M | 0.49% |
| 38 | LAVA THERAPEUTICS NV | N51517105 | 2,400,000 | $4.9M | 0.38% |
| 39 | KINNATE BIOPHARMA INC | 49705R105 | 815,707 | $2.5M | 0.19% |
| 40 | MARQETA INC | MQ | 441,558 | $2.2M | 0.17% |
| 41 | SPERO THERAPEUTICS INC | SPRO | 468,902 | $679,908 | 0.05% |